In the cohorts of East Asians, including Chinese, Japanese, and Koreans, the lowest risk of death was seen among persons with a BMI (the weight in kilograms divided by the square of the height in ...

SURMOUNT-CN used lower BMI thresholds reflective of the Asian population: a BMI of 28 or at least 24 with one or more weight-related comorbidities, excluding diabetes. Half of participants were ...

In a phase 2 trial involving Chinese adults with a BMI of at least 30, a 9-mg dose of mazdutide led to a placebo-adjusted reduction in body weight of 15.4% at 24 weeks and of 18.6% at 48 weeks. 26 ...

The study showed a digital version of the China obesity situation based on the BMI (body mass index) classification of overweight and obesity in the country, with 34.8 percent of the 15.8 million ...

As per Chinese BMI classification, 34.8 percent of the studied population was overweight and 14.1 percent was obese. The eligible participants were aged 18 or above.

The people below may be eligible to receive tirzepatide (Mounjaro) on the NHS. This is to ensure patients at greatest risk ...

According to both WHO and Chinese BMI classifications, the prevalence of both overweight individuals and obesity was higher in northern China than southern China, with the highest prevalence seen ...